Cliniboosta partners with major academic centers and premier oncology specialists in China to establish a powerful clinical research network. This network delivers end-to-end support for Investigator-Initiated Trials (IIT) across a wide spectrum of diseases.
The collaboration spans critical therapeutic areas such as oncology, rare diseases, autoimmune disorders, metabolic and chronic diseases, and neurodegenerative conditions. By tapping into the deep expertise and high-quality data from our partner hospitals, we accelerate every step of the clinical process—from trial design and patient identification to data collection. This ensures both scientific integrity and speeds up the clinical translation of novel treatments.
